Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
CampaMed Exec Receives Patent For C-Med-100
June 1, 2000
1 Min Read
CampaMed Exec Receives Patent For C-Med-100
HILLSIDE, N.J.--Ronald Pero, chief scientific officer with CampaMed, has been issuedU.S. Patent #6,039,949 for C-MED-100 cat's claw. The ingredient is distributed exclusivelyby M.W. International Inc., a raw materials supplier based here. C-MED-100 is aproprietary extract of cat's claw (Uncaria tomentosa) with benefits to the immunesystem and DNA repair. For more information, see www.mwinternational.com.
You May Also Like